The news, examined.

Industry Case Studies

Each case study takes one recent deal, partnership, or launch in clinical research and works through what it means for sponsors, sites, and investors.

Latest Case Studies

These are analyses of public events, not client engagements. Each one sets out what happened, why it matters, and what the people affected can do about it.

CS-005
November 2026For sponsorsSiteScore™

PSI and Appian Automate Site Selection: Faster Process, Same Data Question

On October 28, 2026, PSI CRO and Appian launched an AI-driven workflow for identifying and selecting trial sites. It is one of several such launches this year. For sponsors, the useful question is not how fast the process runs but what data it runs on.

Read the Full Case Study →
CS-004
November 2026For sitesSiteScore™ + FeasComplete™

Ryght AI's Free Site Search: Your Site Is Being Ranked, Whether You Take Part or Not

In April 2026, Ryght AI launched a free search engine that ranks clinical trial sites worldwide, and in May ASCO began using Ryght's platform to choose sites for a breast cancer study. Sites are now being profiled and ranked from data they did not supply.

Read the Full Case Study →
CS-003
November 2026For investorsSiteScore™

Fengate and Clinical Research of West Florida: What a Platform Buyer Needs to Know About a Site

In October 2026, Fengate Private Equity took a majority stake in Clinical Research of West Florida, a 30-year-old Tampa Bay site business, with plans to build a regional network around it. The deal is a useful example of what a buyer has to verify before treating a site as a platform.

Read the Full Case Study →
CS-002
November 2026For investorsSiteScore™

Summit and Dallas Research Institute: Buying Therapeutic Depth, One Site at a Time

In September 2026, Summit Clinical Research Solutions added Dallas Research Institute, a two-year-old metabolic and liver disease site, to its Pinnacle network. The deal shows how specialist networks grow, and why a young site is hard to assess from the outside.

Read the Full Case Study →
CS-001
November 2026For sponsorsSiteScore™

Headlands Research Changes Hands: Does Consolidation Make Sites Better?

THL Partners agreed in August 2025 to buy Headlands Research from KKR, moving one of the largest site networks from one private equity owner to another. Buyers say scale brings consistency. Critics say it brings risk. Sponsors need a way to tell, site by site.

Read the Full Case Study →

How We Write These

Our case studies are information first. The analysis has to stand on its own before we say anything about our own products.

Built on press releases, published research, and trade reporting, all cited
Company claims are labeled as claims, not presented as findings
Companies named are not Clinitiative clients unless stated
Each piece is written for one audience: sponsors, sites, or investors
Our own products appear only in the closing section

The Tools Behind the Analysis

SiteScore™ verifies and benchmarks clinical research site performance. FeasComplete™ helps sites answer feasibility requests faster.